COMT and cholangiocarcinoma: Furthermore, the expression of COMT was a favorable factor for CCA patients (Figure 3D, HR = 0.453, log-rank p value = 0.0023), and HSD17B1 was a risk factor for CCA patients (Figure 3E, HR = 0.453, log-rank p value = 0.00023).